Harvard Bioscience, Inc. (HBIO) vs Milestone Scientific, Inc. (MLSS)
- Harvard Bioscience, Inc. HBIO 8.09 −2.65%
- Milestone Scientific, Inc. MLSS 0.33 0.00%
Harvard Bioscience, Inc. and Milestone Scientific, Inc. are both Medical Instruments & Supplies companies. Harvard Bioscience, Inc. is the larger, with a market value of $37.8M against $29.6M — 1.3× the size. Milestone Scientific, Inc. grew revenue faster over the last twelve months: 3.72% against −1.06%. Harvard Bioscience, Inc. has the higher net margin (−11.9% vs −44.0%) and the higher return on invested capital (−0.41% vs −136.2%). Across the 18 metrics below, Harvard Bioscience, Inc. leads on 10 and Milestone Scientific, Inc. on 8.
Valuation
Profitability
| Metric | HBIO | MLSS | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 58.16% | 70.23% | 54.29% |
| Operating margin | (0.28%) | (43.56%) | 1.07% |
| Net margin | (11.86%) | (43.98%) | (1.61%) |
| Free cash flow margin | (2.09%) | (6.98%) | 1.08% |
| Return on equity | (89.95%) | (121.68%) | (1.32%) |
| Return on assets | (13.32%) | (50.54%) | 0.00% |
| Return on invested capital | (0.41%) | (136.16%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack